-
1
-
-
0030968195
-
Contractile properties of afferent and efferent arterioles
-
Ito S, Abe K. Contractile properties of afferent and efferent arterioles. Clin Exp Pharmacol Physiol 1997; 24:532-5.
-
(1997)
Clin Exp Pharmacol Physiol
, vol.24
, pp. 532-535
-
-
Ito, S.1
Abe, K.2
-
2
-
-
70349648858
-
The renal circulation
-
Massry SG, Glassock RJ, eds, Philadelphia: Lippincott Williams & Wilkins
-
Paul RV, Ploth DW. The renal circulation. In: Massry SG, Glassock RJ, eds. Textbook of Nephrology. Philadelphia: Lippincott Williams & Wilkins, 2001; 43-55.
-
(2001)
Textbook of Nephrology
, pp. 43-55
-
-
Paul, R.V.1
Ploth, D.W.2
-
3
-
-
0029967456
-
Interactions between arterial pressure and sodium excretion
-
Navar LG, Majid DS. Interactions between arterial pressure and sodium excretion. Curr Opin Nephrol Hypertens 1996; 5:64-714.
-
(1996)
Curr Opin Nephrol Hypertens
, vol.5
, pp. 64-714
-
-
Navar, L.G.1
Majid, D.S.2
-
6
-
-
84889486959
-
Kidney and endocrine system: eicosaenoids
-
Massry SG, Glassock RJ, eds, Philadelphia: Lippincott Williams & Wilkins
-
Khan RZ, Badr KF. Kidney and endocrine system: eicosaenoids. In: Massry SG, Glassock RJ, eds. Textbook of Nephrology. Philadelphia: Lippincott Williams & Wilkins, 2001; 151-607.
-
(2001)
Textbook of Nephrology
, pp. 151-607
-
-
Khan, R.Z.1
Badr, K.F.2
-
7
-
-
0003046047
-
The renin-angiotensin systems: renal mechanisms and circulatory homeostasis
-
Seldin DW, Giebish G, eds, New York: Raven Press
-
Hall JE, Brands MW. The renin-angiotensin systems: renal mechanisms and circulatory homeostasis. In: Seldin DW, Giebish G, eds. The Kidney: Physiology and Pathophysiology. New York: Raven Press, 1992; 1475-9.
-
(1992)
The Kidney: Physiology and Pathophysiology
, pp. 1475-1479
-
-
Hall, J.E.1
Brands, M.W.2
-
8
-
-
84889462673
-
Renin angiotensin system
-
Massry SG, Glassock RJ, eds, Philadelphia: Lippincott Williams & Wilkins
-
Benabe JE, Martinez Maldonado M. Renin angiotensin system. In: Massry SG, Glassock RJ, eds. Textbook of Nephrology. Philadelphia: Lippincott Williams & Wilkins, 2001; 166-172.
-
(2001)
Textbook of Nephrology
, pp. 166-172
-
-
Benabe, J.E.1
Martinez Maldonado, M.2
-
10
-
-
0021348796
-
Risk factors for nephrotoxicity in patients treated with aminoglycoside
-
Moore SD, Smith CR, Lipsky JJ et al. Risk factors for nephrotoxicity in patients treated with aminoglycoside. Ann Intern Med 1984; 100:352-7.
-
(1984)
Ann Intern Med
, vol.100
, pp. 352-357
-
-
Moore, S.D.1
Smith, C.R.2
Lipsky, J.J.3
-
11
-
-
0020083449
-
Aminoglycoside inhibition of a renal phosphatidylinositol phospholipase C
-
Lipsky JJ, Lietman PS. Aminoglycoside inhibition of a renal phosphatidylinositol phospholipase C. J Pharmacol Exp Ther 1982; 220:287-91.
-
(1982)
J Pharmacol Exp Ther
, vol.220
, pp. 287-291
-
-
Lipsky, J.J.1
Lietman, P.S.2
-
12
-
-
0040724060
-
The renal response to immunological injury
-
Brenner BM, Rector FC, eds, Philadelphia: WB Saunders
-
Wilson CB, Dixon FJ. The renal response to immunological injury. In: Brenner BM, Rector FC, eds. The Kidney. Philadelphia: WB Saunders, 1986; 800-90.
-
(1986)
The Kidney
, pp. 800-890
-
-
Wilson, C.B.1
Dixon, F.J.2
-
14
-
-
0027452759
-
Immune-complex glomerulonephritis: deposits plus interest
-
Appel GB. Immune-complex glomerulonephritis: deposits plus interest. N Engl J Med 1993; 328:505-6.
-
(1993)
N Engl J Med
, vol.328
, pp. 505-506
-
-
Appel, G.B.1
-
15
-
-
4244107995
-
Pharmacokinetics and pharmacodynamics in cirrhosis
-
Epstein M, ed, Baltimore: Williams & Wilkins
-
Brater DC. Pharmacokinetics and pharmacodynamics in cirrhosis. In: Epstein M, ed. The Kidney in Liver Disease. Baltimore: Williams & Wilkins, 1988; 551-71.
-
(1988)
The Kidney in Liver Disease
, pp. 551-571
-
-
Brater, D.C.1
-
16
-
-
0020628124
-
Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites. Relationship between the diuretic response and the activity of the renin-aldosterone system
-
Perez-Ayuso RM, Arroyo V, Planas R et al. Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites. Relationship between the diuretic response and the activity of the renin-aldosterone system. Gastroenterology 1983; 84:961-8.
-
(1983)
Gastroenterology
, vol.84
, pp. 961-968
-
-
Perez-Ayuso, R.M.1
Arroyo, V.2
Planas, R.3
-
17
-
-
0014954012
-
Compartmentalization of ascites and edema in patients with hepatic cirrhosis
-
Shear L, Ching S, Gabudza GJ. Compartmentalization of ascites and edema in patients with hepatic cirrhosis. N Engl J Med 1970; 282:1391-6.
-
(1970)
N Engl J Med
, vol.282
, pp. 1391-1396
-
-
Shear, L.1
Ching, S.2
Gabudza, G.J.3
-
18
-
-
0022486868
-
Rapid diuresis in patients with ascites from chronic liver disease: the importance of peripheral edema
-
Pockros PJ, Reynolds TB. Rapid diuresis in patients with ascites from chronic liver disease: the importance of peripheral edema. Gastroenterology 1986; 90:1827-33.
-
(1986)
Gastroenterology
, vol.90
, pp. 1827-1833
-
-
Pockros, P.J.1
Reynolds, T.B.2
-
19
-
-
0023224641
-
Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study
-
Ginès P, Arroyo V, Quintero E et al. Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study. Gastroenterology 1987; 1993:234-41.
-
(1987)
Gastroenterology
, vol.1993
, pp. 234-241
-
-
Ginès, P.1
Arroyo, V.2
Quintero, E.3
-
20
-
-
0028417970
-
Hepatorenal syndrome: emerging perspectives of pathophysiology and therapy
-
Epstein M. Hepatorenal syndrome: emerging perspectives of pathophysiology and therapy. J Am Soc Nephrol 1994; 4:1735-53.
-
(1994)
J Am Soc Nephrol
, vol.4
, pp. 1735-1753
-
-
Epstein, M.1
-
21
-
-
0023878150
-
Low serum creatinine levels in severe hepatic disease
-
Takabatake T, Ohta H, Ishida Y et al. Low serum creatinine levels in severe hepatic disease. Arch Intern Med 1988; 148:1313-15.
-
(1988)
Arch Intern Med
, vol.148
, pp. 1313-1315
-
-
Takabatake, T.1
Ohta, H.2
Ishida, Y.3
-
22
-
-
0027952795
-
Limitations of serum creatinine levels and creatinine clearance as filtration markers in cirrhosis
-
Caregaro L, Menon F, Angeli P et al. Limitations of serum creatinine levels and creatinine clearance as filtration markers in cirrhosis. Arch Intern Med 1994; 154:201-5.
-
(1994)
Arch Intern Med
, vol.154
, pp. 201-205
-
-
Caregaro, L.1
Menon, F.2
Angeli, P.3
-
23
-
-
0037310730
-
Assessing renal function in cirrhotic patients: problems and pitfalls
-
Sherman DS, Fish DN, Teitelbaum I. Assessing renal function in cirrhotic patients: problems and pitfalls. Am J Kidney Dis 2003; 41:269-78.
-
(2003)
Am J Kidney Dis
, vol.41
, pp. 269-278
-
-
Sherman, D.S.1
Fish, D.N.2
Teitelbaum, I.3
-
24
-
-
0015237292
-
Inhibition of prostaglandin synthesis as a mechanism of action for the aspirin-like drugs
-
Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for the aspirin-like drugs. Nature [New Biol] 1971; 231:232-5.
-
(1971)
Nature [New Biol]
, vol.231
, pp. 232-235
-
-
Vane, J.R.1
-
25
-
-
0020567626
-
Sympathetic nervous system activity, renin-angiotensin system and renal excretion of prostaglandin E2 in cirrhosis. Relationship to functional renal failure and sodium and water excretion
-
Arroyo V, Planas R, Gaya R et al. Sympathetic nervous system activity, renin-angiotensin system and renal excretion of prostaglandin E2 in cirrhosis. Relationship to functional renal failure and sodium and water excretion. Eur J Clin Invest 1983; 13:271-8.
-
(1983)
Eur J Clin Invest
, vol.13
, pp. 271-278
-
-
Arroyo, V.1
Planas, R.2
Gaya, R.3
-
26
-
-
0020646932
-
Urinary thromboxane B2 and prostaglandin E2 in the hepatorenal syndrome: evidence of vasoconstrictor and decreased vasodilator factors
-
Zipser RD, Radvan GH, Kronborg IJ et al. Urinary thromboxane B2 and prostaglandin E2 in the hepatorenal syndrome: evidence of vasoconstrictor and decreased vasodilator factors. Gastroenterology 1983; 84:697-703.
-
(1983)
Gastroenterology
, vol.84
, pp. 697-703
-
-
Zipser, R.D.1
Radvan, G.H.2
Kronborg, I.J.3
-
27
-
-
0018389197
-
Effect of indomethacin and prostaglandin A1 in renal function and plasma renin activity in alcoholic liver disease
-
Boyer TD, Zia PK, Reynolds TB. Effect of indomethacin and prostaglandin A1 in renal function and plasma renin activity in alcoholic liver disease. Gastroenterology 1979; 77:215-22.
-
(1979)
Gastroenterology
, vol.77
, pp. 215-222
-
-
Boyer, T.D.1
Zia, P.K.2
Reynolds, T.B.3
-
28
-
-
0018487350
-
Prostaglandins: modulators of renal function and pressor resistance in chronic liver disease
-
Zipser RD, Hoefs JC, Speckart PF et al. Prostaglandins: modulators of renal function and pressor resistance in chronic liver disease. J Clin Endocrinol Metab 1979; 48:895-900.
-
(1979)
J Clin Endocrinol Metab
, vol.48
, pp. 895-900
-
-
Zipser, R.D.1
Hoefs, J.C.2
Speckart, P.F.3
-
29
-
-
0020683613
-
Acetylsalicylic acid suppresses the renal hemodynamic effect and reduces the diuretic action of furosemide in cirrhosis with ascites
-
Planas R, Arroyo V, Rimola A et al. Acetylsalicylic acid suppresses the renal hemodynamic effect and reduces the diuretic action of furosemide in cirrhosis with ascites. Gastroenterology 1983; 84:247-52.
-
(1983)
Gastroenterology
, vol.84
, pp. 247-252
-
-
Planas, R.1
Arroyo, V.2
Rimola, A.3
-
30
-
-
0020700134
-
Effects of inhibitors of prostaglandin synthesis on induced diuresis in cirrhosis
-
Mirouze D, Zipser RD, Reynolds TB. Effects of inhibitors of prostaglandin synthesis on induced diuresis in cirrhosis. Hepatology 1983; 3:50-5.
-
(1983)
Hepatology
, vol.3
, pp. 50-55
-
-
Mirouze, D.1
Zipser, R.D.2
Reynolds, T.B.3
-
32
-
-
0021351830
-
Effects of sulindac and ibuprofen in patients with chronic glomerular disease. Evidence for the dependence of renal function on prostacyclin
-
Ciabattoni G, Cinotti GA, Pierucci A et al. Effects of sulindac and ibuprofen in patients with chronic glomerular disease. Evidence for the dependence of renal function on prostacyclin. N Engl J Med 1984; 310:279-83.
-
(1984)
N Engl J Med
, vol.310
, pp. 279-283
-
-
Ciabattoni, G.1
Cinotti, G.A.2
Pierucci, A.3
-
33
-
-
0022621645
-
Sulindac reduces the urinary excretion of prostaglandins and impairs renal function in cirrhosis with ascites
-
Quintero E, Ginès P, Arroyo V et al. Sulindac reduces the urinary excretion of prostaglandins and impairs renal function in cirrhosis with ascites. Nephron 1986; 42:298-303.
-
(1986)
Nephron
, vol.42
, pp. 298-303
-
-
Quintero, E.1
Ginès, P.2
Arroyo, V.3
-
34
-
-
0029024096
-
The effect of misoprostol on indomethacin induced renal dysfunction in well compensated cirrhosis
-
Wong F, Massie D, Hsu P et al. The effect of misoprostol on indomethacin induced renal dysfunction in well compensated cirrhosis. J Hepatol 1995; 23:1-7.
-
(1995)
J Hepatol
, vol.23
, pp. 1-7
-
-
Wong, F.1
Massie, D.2
Hsu, P.3
-
35
-
-
0028834897
-
The effects of chronic administration of indomethacin and misoprostol on renal function in cirrhotic patients with and without ascites
-
Hsia HC, Lin HC, Tsai YT et al. The effects of chronic administration of indomethacin and misoprostol on renal function in cirrhotic patients with and without ascites. Scand J Gastroenterol 1995; 30:1194-9.
-
(1995)
Scand J Gastroenterol
, vol.30
, pp. 1194-1199
-
-
Hsia, H.C.1
Lin, H.C.2
Tsai, Y.T.3
-
36
-
-
0036679125
-
Effects of misoprostol on ibuprofen-induced renal dysfunction in patients with decompensated cirrhosis: results of a double-blind placebo-controlled parallel group study
-
Ackerman Z, Cominelli F, Reynolds TB. Effects of misoprostol on ibuprofen-induced renal dysfunction in patients with decompensated cirrhosis: results of a double-blind placebo-controlled parallel group study. Am J Gastroenterol 2002; 97:2033-9.
-
(2002)
Am J Gastroenterol
, vol.97
, pp. 2033-2039
-
-
Ackerman, Z.1
Cominelli, F.2
Reynolds, T.B.3
-
37
-
-
0027501873
-
Effects of imidazolesalicylate on renal function and the diuretic action of furosemide in cirrhotic patients with ascites
-
Salerno F, Lorenzano E, Maggi A et al. Effects of imidazolesalicylate on renal function and the diuretic action of furosemide in cirrhotic patients with ascites. J Hepatol 1993; 19:279-84.
-
(1993)
J Hepatol
, vol.19
, pp. 279-284
-
-
Salerno, F.1
Lorenzano, E.2
Maggi, A.3
-
38
-
-
0024381125
-
Comparative analgesic and anti-inflammatory properties of sodium salicylate and acetylsalicylic acid (aspirin) in rheumatoid arthritis
-
Preston SJ, Arnold MH, Beller EM et al. Comparative analgesic and anti-inflammatory properties of sodium salicylate and acetylsalicylic acid (aspirin) in rheumatoid arthritis. Br J Clin Pharmacol 1989; 27:607-11.
-
(1989)
Br J Clin Pharmacol
, vol.27
, pp. 607-611
-
-
Preston, S.J.1
Arnold, M.H.2
Beller, E.M.3
-
39
-
-
3042721338
-
Application of imidazole as a selective inhibitor of thromboxane synthetase in human platelets
-
Needelman P, Raz A, Ferrendelli JA, Minkes M. Application of imidazole as a selective inhibitor of thromboxane synthetase in human platelets. Proc Natl Acad Sci USA 1977; 74:1716-20. 40 deCraen AJM, DiGiulio G, Lampe-Schoenmaeckers AEJM et al. Analgesic efficacy and safety of paracetamol-codeine combinations versus paracetamol alone: a systematic review. Br Med J 1996; 313:321-5.
-
(1977)
Proc Natl Acad Sci USA
, vol.74
, pp. 1716-20
-
-
Needelman, P.1
Raz, A.2
Ferrendelli, J.A.3
Minkes, M.4
-
40
-
-
0029787774
-
Analgesic efficacy and safety of paracetamol-codeine combinations versus paracetamol alone: a systematic review
-
deCraen AJM, DiGiulio G, Lampe-Schoenmaeckers AEJM et al. Analgesic efficacy and safety of paracetamol-codeine combinations versus paracetamol alone: a systematic review. Br Med J 1996; 313:321-5.
-
(1996)
Br Med J
, vol.313
, pp. 321-325
-
-
DeCraen, A.J.M.1
DiGiulio, G.2
Lampe-Schoenmaeckers, A.E.J.M.3
-
41
-
-
0029094577
-
Acute renal failure due to acetaminophen ingestion: a case report and review of the literature
-
Blakely P, McDonald BR. Acute renal failure due to acetaminophen ingestion: a case report and review of the literature. J Am Soc Nephrol 1995; 6:48-53.
-
(1995)
J Am Soc Nephrol
, vol.6
, pp. 48-53
-
-
Blakely, P.1
McDonald, B.R.2
-
43
-
-
0042666923
-
JTE-522, a cyclooxygenase-2 inhibitor, is an effective chemopreventive agent against rat experimental liver fibrosis
-
Yamamoto H, Kondo M, Nakamori S et al. JTE-522, a cyclooxygenase-2 inhibitor, is an effective chemopreventive agent against rat experimental liver fibrosis. Gastroenterology 2003; 125:556-71.
-
(2003)
Gastroenterology
, vol.125
, pp. 556-571
-
-
Yamamoto, H.1
Kondo, M.2
Nakamori, S.3
-
44
-
-
0032952505
-
Selective inhibition of cyclooxygenase 2 spares renal function and prostaglandin synthesis in cirrhotic rats with ascites
-
Bosch-Marcé M, Clària J, Titos E et al. Selective inhibition of cyclooxygenase 2 spares renal function and prostaglandin synthesis in cirrhotic rats with ascites. Gastroenterology 1999; 116:1167-75.
-
(1999)
Gastroenterology
, vol.116
, pp. 1167-1175
-
-
Bosch-Marcé, M.1
Clària, J.2
Titos, E.3
-
45
-
-
0028034970
-
Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction
-
Harris RC, McKanna JA, Akai Y et al. Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction. J Clin Invest 1994; 94:2504-10.
-
(1994)
J Clin Invest
, vol.94
, pp. 2504-2510
-
-
Harris, R.C.1
McKanna, J.A.2
Akai, Y.3
-
46
-
-
0030860640
-
Renal identification of cyclooxygenase-2 in a subset of thick ascending limb cells
-
Vio CP, Cespedes C, Gallardo P et al. Renal identification of cyclooxygenase-2 in a subset of thick ascending limb cells. Hypertension 1997; 30:687-92.
-
(1997)
Hypertension
, vol.30
, pp. 687-692
-
-
Vio, C.P.1
Cespedes, C.2
Gallardo, P.3
-
47
-
-
0036043074
-
Renal effects of nonselective NSAIDs and coxibs
-
Weir MR. Renal effects of nonselective NSAIDs and coxibs. Cleve Clin J Med 2002; 69 (Suppl. 1):S153-S158.
-
(2002)
Cleve Clin J Med
, vol.69
, Issue.SUPPL. 1
-
-
Weir, M.R.1
-
48
-
-
85086352393
-
Rofecoxib induced renal dysfunction in a patient with compensated cirrhosis and heart failure
-
Ofran Y, Bursztyn, M, Ackerman Z. Rofecoxib induced renal dysfunction in a patient with compensated cirrhosis and heart failure. Am J Gastroenterol 2001; 96:1941.
-
(2001)
Am J Gastroenterol
, vol.96
, pp. 1941
-
-
Ofran, Y.1
Bursztyn, M.2
Ackerman, Z.3
-
49
-
-
0034006428
-
Are selective cyclooxygenase-2 inhibitors nephrotoxic?
-
Perazella MA, Eras J. Are selective cyclooxygenase-2 inhibitors nephrotoxic? Am J Kidney Dis 2000; 35:937-40.
-
(2000)
Am J Kidney Dis
, vol.35
, pp. 937-940
-
-
Perazella, M.A.1
Eras, J.2
-
50
-
-
0028182409
-
Novel non-steroidal antiinflammatory drug derivatives with markedly reduced ulcerogenic properties in the rat
-
Wallace JL, Reuter B, Cicala C et al. Novel non-steroidal antiinflammatory drug derivatives with markedly reduced ulcerogenic properties in the rat. Gastroenterology 1994; 107:173-9.
-
(1994)
Gastroenterology
, vol.107
, pp. 173-179
-
-
Wallace, J.L.1
Reuter, B.2
Cicala, C.3
-
51
-
-
0028352533
-
Nitric oxide in the kidney: synthesis, localization, and function
-
Bachman S, Mundel P. Nitric oxide in the kidney: synthesis, localization, and function. Am J Kidney Dis 1994; 24:112-29.
-
(1994)
Am J Kidney Dis
, vol.24
, pp. 112-129
-
-
Bachman, S.1
Mundel, P.2
-
52
-
-
0018883872
-
Double-blind comparison of the nephrotoxicity and auditory toxicity of gentamicin and tobramycin
-
Smith CR, Lipsky JJ, Laskkin OL et al. Double-blind comparison of the nephrotoxicity and auditory toxicity of gentamicin and tobramycin. N Eng J Med 1980; 302: 1106-9.
-
(1980)
N Eng J Med
, vol.302
, pp. 1106-1109
-
-
Smith, C.R.1
Lipsky, J.J.2
Laskkin, O.L.3
-
53
-
-
0017058567
-
Persistence of sisomycin and gentamicin in renal cortex and medulla compared with other organs and serum of rats
-
Fabre J, Rudhardt, Blanchard P, Regamey C. Persistence of sisomycin and gentamicin in renal cortex and medulla compared with other organs and serum of rats. Kidney Int 1976; 10:444-8.
-
(1976)
Kidney Int
, vol.10
, pp. 444-448
-
-
Fabre, J.R.1
Blanchard, P.2
Regamey, C.3
-
54
-
-
0037016726
-
Megalin deficiency offers protection from renal aminoglycoside accumulation
-
Schmitz C, Hilper J, Jacobsen C et al. Megalin deficiency offers protection from renal aminoglycoside accumulation. J Biol Chem 2002; 277:618-22.
-
(2002)
J Biol Chem
, vol.277
, pp. 618-622
-
-
Schmitz, C.1
Hilper, J.2
Jacobsen, C.3
-
55
-
-
0020965819
-
Aminoglycoside nephrotoxicity
-
Bennett WM. Aminoglycoside nephrotoxicity. Nephron 1983; 35:73-7.
-
(1983)
Nephron
, vol.35
, pp. 73-77
-
-
Bennett, W.M.1
-
56
-
-
0018125493
-
Early detection of aminoglycoside nephrotoxicity with urinary β2-microglobulin
-
Schentag GG, Surfin TA, Plaut ME et al. Early detection of aminoglycoside nephrotoxicity with urinary β2-microglobulin. J Med 1978; 9:201-10.
-
(1978)
J Med
, vol.9
, pp. 201-210
-
-
Schentag, G.G.1
Surfin, T.A.2
Plaut, M.E.3
-
58
-
-
0021803064
-
Tubular dysfunction in the deeply jaundiced patient with hepatorenal syndrome
-
Rector WG, Kanel GC, Rakela J, Reynolds TB. Tubular dysfunction in the deeply jaundiced patient with hepatorenal syndrome. Hepatology 1985; 5:321-26.
-
(1985)
Hepatology
, vol.5
, pp. 321-326
-
-
Rector, W.G.1
Kanel, G.C.2
Rakela, J.3
Reynolds, T.B.4
-
59
-
-
0022728614
-
Increased risk of renal dysfunction due to interaction of liver disease and aminoglycosides
-
Moore RD, Smith CR, Lietman PS. Increased risk of renal dysfunction due to interaction of liver disease and aminoglycosides. Am J Med 1986; 80:1093-7.
-
(1986)
Am J Med
, vol.80
, pp. 1093-1097
-
-
Moore, R.D.1
Smith, C.R.2
Lietman, P.S.3
-
60
-
-
84889491604
-
Cytoplasmatic and membrane effects of aminoglycosides. A hypothesis for the mechanism of aminoglycoside toxicity
-
Solez K, Whelton A, eds, New York: Marcel Dekker
-
Lipsky JJ, Lefkowith J, Lietman PS. Cytoplasmatic and membrane effects of aminoglycosides. A hypothesis for the mechanism of aminoglycoside toxicity. In: Solez K, Whelton A, eds. Acute Renal Failure, Correlations between Morphology and Function. New York: Marcel Dekker, 1984; 261-71.
-
(1984)
Acute Renal Failure, Correlations between Morphology and Function
, pp. 261-271
-
-
Lipsky, J.J.1
Lefkowith, J.2
Lietman, P.S.3
-
61
-
-
0034993059
-
Effect of dimethylsulfoxide on gentamicin-induced nephrotoxicity in rats
-
Ali BH, Mousa HM. Effect of dimethylsulfoxide on gentamicin-induced nephrotoxicity in rats. Hum Exp Toxicol 2001; 20:199-203.
-
(2001)
Hum Exp Toxicol
, vol.20
, pp. 199-203
-
-
Ali, B.H.1
Mousa, H.M.2
-
62
-
-
0021907953
-
Acute effects of captopril on systemic and renal hemodynamics and on renal function in cirrhotic patients with ascites
-
Pariente EA, Bataille C, Bercoff E, Lebrec D. Acute effects of captopril on systemic and renal hemodynamics and on renal function in cirrhotic patients with ascites. Gastroenterology 1985; 88:1255-9.
-
(1985)
Gastroenterology
, vol.88
, pp. 1255-1259
-
-
Pariente, E.A.1
Bataille, C.2
Bercoff, E.3
Lebrec, D.4
-
63
-
-
0023183830
-
Effects of captopril on renal function in patients with cirrhosis and ascites
-
Daskalopoulos G, Pinzani M, Murray N et al. Effects of captopril on renal function in patients with cirrhosis and ascites. J Hepatol 1987; 4:330-6.
-
(1987)
J Hepatol
, vol.4
, pp. 330-336
-
-
Daskalopoulos, G.1
Pinzani, M.2
Murray, N.3
-
64
-
-
0004574680
-
Inhibition of the conversion of angiotensin I to II and potentiation of bradykinin by small peptides present in Bothrops jararaca venom
-
Greene LJ, Camargo ACM, Krieger EM et al. Inhibition of the conversion of angiotensin I to II and potentiation of bradykinin by small peptides present in Bothrops jararaca venom. Circ Res 1972; 31(Suppl. 2):62-71.
-
(1972)
Circ Res
, vol.31
, Issue.SUPPL. 2
, pp. 62-71
-
-
Greene, L.J.1
Camargo, A.C.M.2
Krieger, E.M.3
-
65
-
-
0027274050
-
Captopril inhibits endothelin-1 secretion from endothelial cells through bradykinin
-
Momose N, Fukuo K, Morimoto S, Ogihara T. Captopril inhibits endothelin-1 secretion from endothelial cells through bradykinin. Hypertension 1993; 21:921-4.
-
(1993)
Hypertension
, vol.21
, pp. 921-924
-
-
Momose, N.1
Fukuo, K.2
Morimoto, S.3
Ogihara, T.4
-
66
-
-
0027528296
-
Effects of lowdose captopril on renal hemodynamics and function in patients with cirrhosis of the liver
-
Gentilini P, Romanelli RG, LaVilla G et al. Effects of lowdose captopril on renal hemodynamics and function in patients with cirrhosis of the liver. Gastroenterology 1993; 104:588-94.
-
(1993)
Gastroenterology
, vol.104
, pp. 588-594
-
-
Gentilini, P.1
Romanelli, R.G.2
LaVilla, G.3
-
67
-
-
0026775513
-
Fat-storing cells as liver specific pericytes. Spatial dynamics of agonist-stimulated intracellular calcium transients
-
Pinzani M, Failli P, Ruocco C et al. Fat-storing cells as liver specific pericytes. Spatial dynamics of agonist-stimulated intracellular calcium transients. J Clin Invest 1992; 90: 642-6.
-
(1992)
J Clin Invest
, vol.90
, pp. 642-646
-
-
Pinzani, M.1
Failli, P.2
Ruocco, C.3
-
68
-
-
0034120267
-
Angiotensin II induces contraction and proliferation of human hepatic stellate cells
-
Bataller R, Ginès P, Nicolas JM et al. Angiotensin II induces contraction and proliferation of human hepatic stellate cells. Gastroenterology 2000; 118:1149-56.
-
(2000)
Gastroenterology
, vol.118
, pp. 1149-1156
-
-
Bataller, R.1
Ginès, P.2
Nicolas, J.M.3
-
69
-
-
0032988091
-
Effect of losartan, an angiotensin II receptor antagonist, on portal pressure in cirrhosis
-
Schneider AW, Kalk JF, Klein CP. Effect of losartan, an angiotensin II receptor antagonist, on portal pressure in cirrhosis. Hepatology 1999; 29:334-9.
-
(1999)
Hepatology
, vol.29
, pp. 334-339
-
-
Schneider, A.W.1
Kalk, J.F.2
Klein, C.P.3
-
70
-
-
0035433365
-
Randomized comparison of long-term losartan versus propranolol in lowering portal pressure in cirrhosis
-
Gonzales-Abraldes J, Albillos A, Bañares R et al. Randomized comparison of long-term losartan versus propranolol in lowering portal pressure in cirrhosis. Gastroenterology 2001; 121:382-8.
-
(2001)
Gastroenterology
, vol.121
, pp. 382-388
-
-
Gonzales-Abraldes, J.1
Albillos, A.2
Bañares, R.3
-
71
-
-
0034898990
-
Hemodynamics effects of the angiotensin II receptor antagonist irbesartan in patients with cirrhosis and portal hypertension
-
Schepke M, Werner E, Biecker E et al. Hemodynamics effects of the angiotensin II receptor antagonist irbesartan in patients with cirrhosis and portal hypertension. Gastroenterology 2001; 121:389-95.
-
(2001)
Gastroenterology
, vol.121
, pp. 389-395
-
-
Schepke, M.1
Werner, E.2
Biecker, E.3
-
72
-
-
0036161720
-
Efficacy of irbesartan, a receptor selective antagonist of angiotensin II, in reducing portal hypertension
-
Debernardi-Venon W, Barletti C, Alessandria C et al. Efficacy of irbesartan, a receptor selective antagonist of angiotensin II, in reducing portal hypertension. Dig Dis Sci 2002; 47:401-4.
-
(2002)
Dig Dis Sci
, vol.47
, pp. 401-404
-
-
Debernardi-Venon, W.1
Barletti, C.2
Alessandria, C.3
-
73
-
-
0037903052
-
Portal pressure response to losartan compared with propranolol in patients with cirrhosis
-
De BK, Bandyopadhyay K, Das TK et al. Portal pressure response to losartan compared with propranolol in patients with cirrhosis. Am J Gastroenterol 2003; 98:1371-6.
-
(2003)
Am J Gastroenterol
, vol.98
, pp. 1371-1376
-
-
De, B.K.1
Bandyopadhyay, K.2
Das, T.K.3
-
74
-
-
0025275076
-
Nonpeptide angiotensin II receptor antagonist. VIII. Characterization of functional antagonism displayed by DuP 753, an orally active antihypertensive agent
-
Wong PC, Price WA Jr, Chiu AT et al. Nonpeptide angiotensin II receptor antagonist. VIII. Characterization of functional antagonism displayed by DuP 753, an orally active antihypertensive agent. Exp Ther 1990; 252:719-25.
-
(1990)
Exp Ther
, vol.252
, pp. 719-725
-
-
Wong, P.C.1
Price Jr, W.A.2
Chiu, A.T.3
-
76
-
-
0028145504
-
Nifedipine: its effects on renal hemodynamics and sodium homeostasis in well compensated alcoholic cirrhosis
-
Wong F, Massie D, Hsu P, F Dudley. Nifedipine: its effects on renal hemodynamics and sodium homeostasis in well compensated alcoholic cirrhosis. J Hepatol 1994; 21:64-9.
-
(1994)
J Hepatol
, vol.21
, pp. 64-69
-
-
Wong, F.1
Massie, D.2
Hsu, P.3
Dudley, F.4
-
77
-
-
0022496717
-
Verapamil favorably influences hepatic microvascular exchange and function in rats with cirrhosis of the liver
-
Reichen J, Le M. Verapamil favorably influences hepatic microvascular exchange and function in rats with cirrhosis of the liver. J Clin Invest 1986; 78:448-55.
-
(1986)
J Clin Invest
, vol.78
, pp. 448-455
-
-
Reichen, J.1
Le, M.2
-
78
-
-
0023688192
-
Effects of verapamil on hepatic and systemic hemodynamics and liver function in patients with cirrhosis and portal hypertension
-
Navasa M, Bosch J, Reichen J et al. Effects of verapamil on hepatic and systemic hemodynamics and liver function in patients with cirrhosis and portal hypertension. Hepatology 1988; 8:850-4.
-
(1988)
Hepatology
, vol.8
, pp. 850-854
-
-
Navasa, M.1
Bosch, J.2
Reichen, J.3
-
79
-
-
0024522111
-
Verapamil has no effect on porto-hepatic pressure gradient, hepatic blood flow and elimination function of the liver in patients with liver cirrhosis
-
Vinel JP, Caucanas JP, Combis JM et al. Verapamil has no effect on porto-hepatic pressure gradient, hepatic blood flow and elimination function of the liver in patients with liver cirrhosis. J Hepatol 1989; 8:302-7.
-
(1989)
J Hepatol
, vol.8
, pp. 302-307
-
-
Vinel, J.P.1
Caucanas, J.P.2
Combis, J.M.3
-
80
-
-
0023278326
-
Hemodynamic evaluation of isosorbide dinitrate in alcoholic cirrhosis
-
Blei AT, Garcia-Tsao G, Groszmann RJ et al. Hemodynamic evaluation of isosorbide dinitrate in alcoholic cirrhosis. Gastroenterology 1987; 93:576-83.
-
(1987)
Gastroenterology
, vol.93
, pp. 576-583
-
-
Blei, A.T.1
Garcia-Tsao, G.2
Groszmann, R.J.3
-
81
-
-
0023630437
-
Portal hemodynamics during nitroglycerin administration in cirrhotic patients
-
Garcia-Tsao G, Groszmann RJ. Portal hemodynamics during nitroglycerin administration in cirrhotic patients. Hepatology 1987; 7:805-9.
-
(1987)
Hepatology
, vol.7
, pp. 805-809
-
-
Garcia-Tsao, G.1
Groszmann, R.J.2
-
82
-
-
0024603813
-
Reduction of portal pressure by isosorbide-5-mononitrate in patients with cirrhosis
-
Navasa M, Chesta J, Bosch J, Rodés J. Reduction of portal pressure by isosorbide-5-mononitrate in patients with cirrhosis. Gastroenterology 1989; 96:1110-18.
-
(1989)
Gastroenterology
, vol.96
, pp. 1110-1118
-
-
Navasa, M.1
Chesta, J.2
Bosch, J.3
Rodés, J.4
-
83
-
-
0025906655
-
Propranolol compared with propranolol plus isosorbide-5-mononitrate in patients with cirrhosis and portal hypertension
-
Garcia Pagan JC, Feu F, Bosch J, Rodés J. Propranolol compared with propranolol plus isosorbide-5-mononitrate in patients with cirrhosis and portal hypertension. Ann Intern Med 1990; 114:869-73.
-
(1990)
Ann Intern Med
, vol.114
, pp. 869-873
-
-
Garcia Pagan, J.C.1
Feu, F.2
Bosch, J.3
Rodés, J.4
-
84
-
-
0030003919
-
Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention of variceal bleeding
-
Villanueva C, Balanzo J, Novella MT et al. Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention of variceal bleeding. N Engl J Med 1996; 334:1624-9.
-
(1996)
N Engl J Med
, vol.334
, pp. 1624-1629
-
-
Villanueva, C.1
Balanzo, J.2
Novella, M.T.3
-
85
-
-
0027270291
-
Renal effects of acute isosorbide-5-mononitrate administration in cirrhosis
-
Salmerón JM, del Arbol LR, Ginès A et al. Renal effects of acute isosorbide-5-mononitrate administration in cirrhosis. Hepatology 1993; 17:800-6.
-
(1993)
Hepatology
, vol.17
, pp. 800-806
-
-
Salmerón, J.M.1
Del Arbol, L.R.2
Ginès, A.3
-
86
-
-
0029980430
-
Long-term administration of isosorbide-5-mononitrate does nor impair renal function in cirrhotic patients
-
Salerno F, Borroni G, Lorenzano E et al. Long-term administration of isosorbide-5-mononitrate does nor impair renal function in cirrhotic patients. Hepatology 1996; 23:1135-40.
-
(1996)
Hepatology
, vol.23
, pp. 1135-1140
-
-
Salerno, F.1
Borroni, G.2
Lorenzano, E.3
-
87
-
-
0025912301
-
Tolerance to organic nitrates: evidence, mechanisms, clinical relevance, and strategies for prevention
-
Elkayam U. Tolerance to organic nitrates: evidence, mechanisms, clinical relevance, and strategies for prevention. Ann Intern Med 1991; 114:667-77.
-
(1991)
Ann Intern Med
, vol.114
, pp. 667-677
-
-
Elkayam, U.1
-
88
-
-
0027988534
-
Propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis: long-term hemodynamic and renal effects
-
Morillas RM, Planas R, Cabré E et al. Propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis: long-term hemodynamic and renal effects. Hepatology 1994; 20:1502-8.
-
(1994)
Hepatology
, vol.20
, pp. 1502-1508
-
-
Morillas, R.M.1
Planas, R.2
Cabré, E.3
-
89
-
-
0029092242
-
Long-term effect of nadolol or nadolol plus isosorbide-5-mononitrate on renal function and ascites formation in patients with cirrhosis
-
Merkel C, Gatta A, Donada C et al. Long-term effect of nadolol or nadolol plus isosorbide-5-mononitrate on renal function and ascites formation in patients with cirrhosis. Hepatology 1995; 22:808-13.
-
(1995)
Hepatology
, vol.22
, pp. 808-813
-
-
Merkel, C.1
Gatta, A.2
Donada, C.3
-
90
-
-
0018235646
-
Treatment of bleeding esophageal varices with somatostatin
-
Tyden G, Samnegard H, Thulin L, Friman L. Treatment of bleeding esophageal varices with somatostatin. N Engl J Med 1978; 299:1466-7.
-
(1978)
N Engl J Med
, vol.299
, pp. 1466-1467
-
-
Tyden, G.1
Samnegard, H.2
Thulin, L.3
Friman, L.4
-
91
-
-
0021282453
-
Comparison of intravenous somatostatin and vasopressin in treatment of acute variceal hemorrhage
-
Kravetz D, Bosch J, Terés J et al. Comparison of intravenous somatostatin and vasopressin in treatment of acute variceal hemorrhage. Hepatology 1984; 4:442-6.
-
(1984)
Hepatology
, vol.4
, pp. 442-446
-
-
Kravetz, D.1
Bosch, J.2
Terés, J.3
-
92
-
-
0021986002
-
A prospective randomized controlled clinical trial comparing somatostatin and vasopressin in controlling acute variceal hemorrhage
-
Jenkins SA, Baxter JN, Corbet W et al. A prospective randomized controlled clinical trial comparing somatostatin and vasopressin in controlling acute variceal hemorrhage. Br Med J 1985; 290:275-8.
-
(1985)
Br Med J
, vol.290
, pp. 275-278
-
-
Jenkins, S.A.1
Baxter, J.N.2
Corbet, W.3
-
93
-
-
0022638839
-
Effects of somatostatin on hepatic hemodynamics in the cirrhotic rat
-
Jenkins SA, Devitt P, Day DW et al. Effects of somatostatin on hepatic hemodynamics in the cirrhotic rat. Digestion 1986; 33:126-34.
-
(1986)
Digestion
, vol.33
, pp. 126-134
-
-
Jenkins, S.A.1
Devitt, P.2
Day, D.W.3
-
94
-
-
0025932420
-
Glucagon hinders the effects of somatostatin on portal hypertension
-
Pizcueta MP, Garcia-Pagan JC, Fernández M et al. Glucagon hinders the effects of somatostatin on portal hypertension. Gastroenterology 1991; 101:1710-15.
-
(1991)
Gastroenterology
, vol.101
, pp. 1710-1715
-
-
Pizcueta, M.P.1
Garcia-Pagan, J.C.2
Fernández, M.3
-
95
-
-
0025245472
-
Effects of longacting somatostatin analogue on renal functions
-
Tulassay Z, Tulassay T, Szucs L, Nagi I. Effects of longacting somatostatin analogue on renal functions. Horm Metab Res 1990; 22:555-6.
-
(1990)
Horm Metab Res
, vol.22
, pp. 555-556
-
-
Tulassay, Z.1
Tulassay, T.2
Szucs, L.3
Nagi, I.4
-
96
-
-
0023245525
-
Renal response to intravenous somatostatin in insulin-dependent diabetic patients and normal subjects
-
Vora J, Owens DR, Luzio S et al. Renal response to intravenous somatostatin in insulin-dependent diabetic patients and normal subjects. J Clin Endocrinol Metab 1987; 64:975-9.
-
(1987)
J Clin Endocrinol Metab
, vol.64
, pp. 975-979
-
-
Vora, J.1
Owens, D.R.2
Luzio, S.3
-
98
-
-
0026472519
-
Effects of somatostatin on renal function in cirrhosis
-
Ginès A, Salmeron JM, Ginès P et al. Effects of somatostatin on renal function in cirrhosis. Gastroenterology 1992; 103:1868-74.
-
(1992)
Gastroenterology
, vol.103
, pp. 1868-1874
-
-
Ginès, A.1
Salmeron, J.M.2
Ginès, P.3
-
99
-
-
0343579427
-
Somatostatin analogue: treatment for portal hypertension?
-
Blei AT. Somatostatin analogue: treatment for portal hypertension? Hepatology 1986; 6:1432-3.
-
(1986)
Hepatology
, vol.6
, pp. 1432-1433
-
-
Blei, A.T.1
-
100
-
-
0027459574
-
Octreotide ameliorates vasodilatation and Na+ retention in portal hypertensive rats
-
Albillos A, Colombato LA, Lee F, Groszmann RJ. Octreotide ameliorates vasodilatation and Na+ retention in portal hypertensive rats. Gastroenterology 1993; 104:575-9.
-
(1993)
Gastroenterology
, vol.104
, pp. 575-579
-
-
Albillos, A.1
Colombato, L.A.2
Lee, F.3
Groszmann, R.J.4
-
101
-
-
0030953521
-
Octreotide longterm treatment in patients with portal hypertension: persistent inhibition of postprandial glucagon response without major changes in renal function
-
Malesci A, Tacconi M, Valentini A et al. Octreotide longterm treatment in patients with portal hypertension: persistent inhibition of postprandial glucagon response without major changes in renal function. J Hepatol 1997; 26:816-25.
-
(1997)
J Hepatol
, vol.26
, pp. 816-825
-
-
Malesci, A.1
Tacconi, M.2
Valentini, A.3
-
102
-
-
0024549439
-
The vasodilator role of adenosine
-
Collis MG. The vasodilator role of adenosine. Pharmacol Ther 1989; 41:143-62.
-
(1989)
Pharmacol Ther
, vol.41
, pp. 143-162
-
-
Collis, M.G.1
-
103
-
-
0022643507
-
Cardiovascular effects of adenosine
-
Fredholm BB, Sollevi A. Cardiovascular effects of adenosine. Clin Physiol 1986; 6:1-21.
-
(1986)
Clin Physiol
, vol.6
, pp. 1-21
-
-
Fredholm, B.B.1
Sollevi, A.2
-
104
-
-
4244042273
-
A proposed role for adenosine in the regulation of renal hemodynamics and renin release
-
Spielman WS, Thompson CI. A proposed role for adenosine in the regulation of renal hemodynamics and renin release. Am J Physiol 1982; 242:F423-F425.
-
(1982)
Am J Physiol
, vol.242
-
-
Spielman, W.S.1
Thompson, C.I.2
-
105
-
-
0021953809
-
Dipyridamole decreases glomerular filtration in the sodium-depleted dog: evidence for mediation by intrarenal adenosine
-
Arend LJ, Thompson CI, Spielman WS. Dipyridamole decreases glomerular filtration in the sodium-depleted dog: evidence for mediation by intrarenal adenosine. Circ Res 1985; 56:242-51.
-
(1985)
Circ Res
, vol.56
, pp. 242-251
-
-
Arend, L.J.1
Thompson, C.I.2
Spielman, W.S.3
-
106
-
-
0021251686
-
Theophylline antagonizes cardiovascular responses to dipyridamole in man without affecting increases in plasma adenosine
-
Sollevi A, Ostergren J, Fagrell B, Hjemdahl P. Theophylline antagonizes cardiovascular responses to dipyridamole in man without affecting increases in plasma adenosine. Acta Physiol Scand 1984; 121:165-71.
-
(1984)
Acta Physiol Scand
, vol.121
, pp. 165-171
-
-
Sollevi, A.1
Ostergren, J.2
Fagrell, B.3
Hjemdahl, P.4
-
107
-
-
0003042071
-
Anticoagulant, thrombolytic and antiplatelet drugs
-
Goodman LS, Gilman A, Rall TW, Nies AS, Taylor P, eds, New York: Pergamon Press
-
Majerus PW, Broze GJ, Miletich JP, Tollefsen DM. Anticoagulant, thrombolytic and antiplatelet drugs. In: Goodman LS, Gilman A, Rall TW, Nies AS, Taylor P, eds. The Pharmacological Basis of Therapeutics. New York: Pergamon Press, 1990; 1311-31.
-
(1990)
The Pharmacological Basis of Therapeutics
, pp. 1311-1331
-
-
Majerus, P.W.1
Broze, G.J.2
Miletich, J.P.3
Tollefsen, D.M.4
-
108
-
-
0027506821
-
Effect of dipyridamole on kidney function in cirrhosis
-
Llach J, Ginès P, Arroyo V et al. Effect of dipyridamole on kidney function in cirrhosis. Hepatology 1993; 17:59-64.
-
(1993)
Hepatology
, vol.17
, pp. 59-64
-
-
Llach, J.1
Ginès, P.2
Arroyo, V.3
-
109
-
-
0020531248
-
Renal effects of aminophylline in hepatic cirrhosis
-
Milani L, Merkel C, Gatta A. Renal effects of aminophylline in hepatic cirrhosis. Eur J Clin Pharmacol 1983; 24:757-60.
-
(1983)
Eur J Clin Pharmacol
, vol.24
, pp. 757-760
-
-
Milani, L.1
Merkel, C.2
Gatta, A.3
-
110
-
-
0015866397
-
Demeclocycline-induced nephrogenic diabetes insipidus: in-vivo and in-vitro studies
-
Singer I, Rotenberg D. Demeclocycline-induced nephrogenic diabetes insipidus: in-vivo and in-vitro studies. Ann Intern Med 1973; 79:679-83.
-
(1973)
Ann Intern Med
, vol.79
, pp. 679-683
-
-
Singer, I.1
Rotenberg, D.2
-
111
-
-
0017887232
-
Superiority of demeclocycline over lithium in the treatment of chronic syndrome of inappropriate antidiuretic hormone
-
Forrest JM, Cox M, Hong C et al. Superiority of demeclocycline over lithium in the treatment of chronic syndrome of inappropriate antidiuretic hormone. N Engl J Med 1978; 298:173-7.
-
(1978)
N Engl J Med
, vol.298
, pp. 173-177
-
-
Forrest, J.M.1
Cox, M.2
Hong, C.3
-
112
-
-
0017093769
-
Demeclocycline treatment of water retention in cirrhosis
-
DeTroyer A, Pilloy W, Broeckaert I et al. Demeclocycline treatment of water retention in cirrhosis. Ann Intern Med 1976; 85:336-7.
-
(1976)
Ann Intern Med
, vol.85
, pp. 336-337
-
-
DeTroyer, A.1
Pilloy, W.2
Broeckaert, I.3
-
113
-
-
0017051776
-
Deterioration of renal function with demeclocycline administration
-
Oster JR, Epstein M, Ulano HB. Deterioration of renal function with demeclocycline administration. Curr Ther Res 1976; 20:794-801.
-
(1976)
Curr Ther Res
, vol.20
, pp. 794-801
-
-
Oster, J.R.1
Epstein, M.2
Ulano, H.B.3
-
114
-
-
0017639711
-
Renal failure associated with demeclocycline in cirrhosis
-
Carrilho F, Bosch J, Arroyo V et al. Renal failure associated with demeclocycline in cirrhosis. Ann Intern Med 1977; 87:195-7.
-
(1977)
Ann Intern Med
, vol.87
, pp. 195-197
-
-
Carrilho, F.1
Bosch, J.2
Arroyo, V.3
-
115
-
-
0021322304
-
Effect of demeclocycline on renal function and urinary prostaglandin E2 and kallikrein in hyponatremic cirrhotics
-
Perez-Ayuso RM, Arroyo V, Camps J et al. Effect of demeclocycline on renal function and urinary prostaglandin E2 and kallikrein in hyponatremic cirrhotics. Nephron 1984; 36:30-7.
-
(1984)
Nephron
, vol.36
, pp. 30-37
-
-
Perez-Ayuso, R.M.1
Arroyo, V.2
Camps, J.3
-
116
-
-
0038282815
-
A systematic review of the antifungal effectiveness and tolerability of Amphotericin B formulations
-
Barrett JP, Vardulaki KA, Conlon C et al. A systematic review of the antifungal effectiveness and tolerability of Amphotericin B formulations. Clin Ther 2003; 25:1295-320.
-
(2003)
Clin Ther
, vol.25
, pp. 1295-1320
-
-
Barrett, J.P.1
Vardulaki, K.A.2
Conlon, C.3
-
117
-
-
0035079024
-
Spontaneous fungal peritonitis (Candida glabrata) in a patient with cirrhosis
-
Nair S, Kumar KS, Sachan P, Corpuz M. Spontaneous fungal peritonitis (Candida glabrata) in a patient with cirrhosis. J Clin Gastroenterol 2001; 32:362-4.
-
(2001)
J Clin Gastroenterol
, vol.32
, pp. 362-364
-
-
Nair, S.1
Kumar, K.S.2
Sachan, P.3
Corpuz, M.4
|